ReviewPathogens (Basel, Switzerland)2024
The Last Mile in Polio Eradication: Program Challenges and Perseverance.
Review in Pathogens (Basel, Switzerland), 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 14 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
14 citing papers in PubMed, 25 citations in OpenAlex.
- Polio transition in the African Region: progress, challenges and prospects for health systems integration.BMC infectious diseases · 2026Review
- Double recombinant nOPV2 vaccine.Nature microbiology · 2026Article
- Congenital Syphilis: From Near-Elimination to Crisis.American journal of public health · 2026Article
- Impediments to Progress Toward Polio Eradication During 2014-2024: Effectively Addressing the Current Challenges.Vaccines · 2025Review
- NanoDeNovo: De Novo Design of Anti-Poliovirus I Sabin Strain Nanobodies by Semi-Automated Computational Pipeline.International journal of molecular sciences · 2025Article
- Sustained Immune Persistence Five Years Post-Completion of Four-Dose sIPV Vaccination.Vaccines · 2025Article
- Community-Based Surveillance of Acute Flaccid Paralysis: A Review on Detection and Reporting Strategy.Journal of epidemiology and global health · 2025Review
- Article
- Harnessing laboratory data for poliovirus eradication: contributions of the Africa regional polio laboratory data management team, 2022 - 2024.Computer methods and programs in biomedicine update · 2025Article
- Navigating change: the ongoing efforts to contain poliovirus in the United States.Frontiers in bioengineering and biotechnology · 2025Article
- Securing the Future: Strategies for Global Polio Vaccine Security Amid Eradication Efforts.Vaccines · 2024Article
- Adherence to COVID-19 vaccination recommendations and vaccine hesitancy in US blood donors.Transfusion · 2024Article
- Polio Epidemiology: Strategies and Challenges for Polio Eradication Post the COVID-19 Pandemic.Vaccines · 2024Article
- Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors at 1 institution in 1 country.
Funding
Abstract
As the Global Polio Eradication Initiative (GPEI) strategizes towards the final steps of eradication, routine immunization schedules evolve, and high-quality vaccination campaigns and surveillance systems remain essential. New tools are consistently being developed, such as the novel oral poliovirus vaccine to combat outbreaks more sustainably, as well as non-infectiously manufactured vaccines such as virus-like particle vaccines to eliminate the risk of resurgence of polio on the eve of a polio-free world. As the GPEI inches towards eradication, re-strategizing in the face of evolving challenges and preparing for unknown risks in the post-certification era are critical.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.